The Healing NET Foundation Mission: To optimize the care of those with neuroendocrine cancer through the education of and collaboration among physicians, health care providers, patients, and caregivers. Click here for TEN FACTS ON NET.

Healing NET is possible with the right treatment by the right team at the right time.

GET INVOLVED

Stay Informed

To receive info about HNF as well as updates on NET treatments and therapies, please join our mailing list.


The Healing NET Foundation was inspired by the work of two physicians - Dr. Eric Liu and Dr. Kjell Oberg. Dr. Oberg (right) has led major research in Europe, translating into successful treatment programs, which are gaining traction in the U.S. Dr. Liu (left) trained directly under Dr. Oberg and was responsible for establishing the first clinical trial in the U.S. for the Ga68, an important tool to diagnose NET patients.

Read more in our About Us section.

Mission Critical: Collaboration

Healing NET works with other organizations to optimize patient care.

We recently partnered with ResearchMatch.org. The site connects volunteers to clinical trials and researchers to trial participants.

 

Tell Your Story

In Telling Your Story, you can give hope, education, and inspiration to another patient or caregiver; you can bring awareness to another colleague; you can make a big difference in fighting NETs. You never know who your story will touch.

Click Here to Tell Your Story

Also view the NET Memorial Wall to celebrate patients who are no longer with us.

Start a discussion

Join the new GI Neuroendocrine Tumor (GI NET) Community at Inspire.com

 

 

ZEBRA Blog

Summit 2018 Faculty.JPG

Read in our Zebra Blog about the 3rd Annual International Healing NET Summit on Feb 22-24 in San Diego.

READ MORE....

Healing Net Foundation

Resources

Information on neuroendocrine cancer (NET) can be hard to come by. Check out our Patient Resources and our Health Care Professional Resources. We celebrate our new partnership with ResearchMatch and Trials Today to support clinical trials.

 

Visit OUR NEWSROOM